Prognostic Implications of <scp> <i>SMARCA4</i> </scp> , <scp> <i>ARID1A</i> </scp> , and Other <scp>BAF</scp> Mutations in Non‐Small Cell Lung Cancer

A growing body of evidence indicates that BAF complex mutations have important prognostic implications. These may be leveraged for risk stratification and therapeutic selection in patients with non-small cell lung cancer.